Co-Suppression of MDR1 (Multidrug Resistance 1) and GCS（glucosylceramide Synthase）restores Sensitivity to Multidrug Resistance Breast Cancer Cells by RNA Interference (RNAi)

Cancer Biology and Therapy - United States
doi 10.4161/cbt.8.12.8374
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Ceramide and Glucosylceramide Upregulate Expression of the Multidrug Resistance Gene MDR1 in Cancer Cells

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
Cell BiologyMolecular Biology
2007English

Stable Reversal of Multidrug Resistance in Colon Cancer Cells by RNA Interference Targeting the MDR1 Gene

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2009English

Correction: Suppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21α-Methylmelianodiol in Lung Cancer Cells

PLoS ONE
Multidisciplinary
2015English

Role of HSP27 in the Multidrug Sensitivity and Resistance of Colon Cancer Cells

Oncology Letters
Cancer ResearchOncology
2020English

Multidrug-Resistance P-Glycoprotein (MDR1) Secretes Platelet-Activating Factor

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2001English

HIF-1α Inhibition Reverses Multidrug Resistance in Colon Cancer Cells via Downregulation of MDR1/P-Glycoprotein

PLoS ONE
Multidisciplinary
2014English

Multidrug Resistance in Prostate Cancer

Oncology Research and Treatment
Cancer ResearchOncologyHematology
2003English

Functional Detection of MDR1/P170 and MRP/P190-mediated Multidrug Resistance in Tumour Cells by Flow Cytometry

British Journal of Cancer
Cancer ResearchOncology
1995English

MDR1/ABCB1polymorphisms and Multidrug Resistance in Epilepsy: In and Out of Fashion

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy